Showing the latest 10 filings. Sign in to filter or browse the full history.
10 of 65 filings·Updated 12 Oct 2026
Showing 10 of 65 filings.
12 Oct 20261 filing
Company UpdateCertificate under SEBI (Depositories and Participants) Regulations, 2018

IPCA Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

No brief for this announcement.This type of announcement aren’t summarised. View the original using the link below
Filed 15:26View Source
22 Sept 20261 filing
Insider Trading / SASTClosure of Trading Window

Ipca Laboratories Limited — Trading window closed from 1st October, 2026 until 48 hours after the declaration of the Company’s unaudited financial results for the 2nd quarter and half year ended 30th September, 2026.

Ipca Laboratories Limited — Trading window closed from 1st October, 2026 until 48 hours after the declaration of the Company’s unaudited financial results for the 2nd quarter and half year ended 30th September, 2026.

Filed 11:43View Source
17 Aug 20262 filings
Company UpdateAnalyst / Investor Meet

Ipca Q1 FY27 earnings call held Aug 14, 2026; transcript available

Meeting Details

  • Date and time: August 14, 2026, 15:30 IST.
  • Type and mode: Earnings conference call, virtual online event.
  • Organizer: DAM Capital Advisors Limited.
  • Recording: Conference is being recorded; transcript available.

Participants

  • Key company participants: Managing Director; Corporate Counsel and Company Secretary.

Purpose

  • Purpose: discuss Q1 FY27 earnings and business update.

Additional Notes

  • Transcript and recording are available for investor access.
Filed 12:07View Source
Company UpdateAnalyst / Investor Meet

Ipca Laboratories Q1 FY27 Earnings Conference Call held Aug 14, 2026; transcript filed

Meeting Details

  • Date and time: 14 August 2026, 15:30 IST.
  • Type and mode: Earnings conference call (virtual).
  • Event: Ipca Q1 FY27 Earnings Conference Call; organised by DAM Capital Advisors.
  • Recording: Conference call was recorded.

Participants

  • Managing Director: A.K. Jain.
  • Corporate Counsel & Company Secretary: Harish Kamath.
  • Moderator: Nitin Agarwal, DAM Capital Advisors Limited.

Purpose

  • Discuss Q1 FY27 earnings and business update.
  • Investor Q&A session following presentation.

Additional Notes

  • Transcript of the conference call is included in the filing.
Filed 11:59View Source
14 Aug 20265 filings
Company UpdateAnalyst / Investor Meet

Ipca Laboratories Holds Q1 FY27 Earnings Conference Call on 14 August 2026; Audio Recording Available

Meeting Details

  • Date and time: 14 August 2026, 15:30 IST.
  • Type and mode: group conference call, virtual (audio).
  • Organiser: Ipca Laboratories Limited.
  • Purpose: discuss Q1 FY27 earnings and business update.

Participants

  • Key company participant: Corporate Counsel & Company Secretary.

Availability

  • Audio recording of conference call available.
Filed 17:26View Source
Company UpdateAnalyst / Investor Meet

Ipca Laboratories holds virtual Q1FY27 earnings conference call on 14 August 2026

Meeting Details

  • Date and time: 14 August 2026, 15:30 IST.
  • Type/Mode: Group virtual conference call (audio).
  • Event: Ipca Laboratories Limited Q1FY27 earnings conference call.

Participants

  • Key company participant: Corporate Counsel & Company Secretary.

Purpose

  • Purpose: discuss Q1FY27 earnings and business update.

Additional Notes

  • Audio recording of conference call available.
Filed 17:18View Source
Company UpdateCopy of Newspaper Publication

IPCA Laboratories Limited has informed the Exchange about Copy of Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:54View Source
Company UpdateNewspaper Publication

Copy of Newspaper Publication

No brief for this announcement.Newspaper publications aren’t summarised. View the original using the link below
Filed 15:48View Source
AGM/EGMAGM

Ipca Laboratories 76th AGM on 13 August 2026: resolutions approved, dividend declared, ED appointment updates

AGM Details

  • AGM held on 13 August 2026 at 3:30 PM IST via VC/OAVM.
  • Record date for voting: 7 August 2026.
  • Total shareholders on record: 85,465.
  • Remote e-voting window: 10–12 August 2026.

Key Resolutions

  • Resolution 1: Adoption of Audited Financial Statements and Consolidated Statements for FY2026.
  • Resolution 2: Declaration of dividend on equity shares.
  • Resolution 3: Re-appointment of Ajit Kumar Jain as Director by rotation.
  • Resolution 4: Re-appointment of Pranay Godha as Director by rotation.
  • Resolution 5: Re-appointment of Prashant Godha as Executive Director; remuneration.
  • Resolution 6: Ratification of remuneration to ABK & Associates for cost audit 2026-27.

Voting Results

  • Resolution 1: Passed; 99.98% in favour, 0.02% against.
  • Resolution 2: Passed; 100.00% in favour.
  • Resolution 3: Passed; 99.41% in favour.
  • Resolution 4: Passed; 99.45% in favour.
  • Resolution 5: Passed; 90.26% in favour.
  • Resolution 6: Passed; 100.00% in favour.

Dividend

  • Dividend on equity shares was declared.

Director Changes

  • Ajit Kumar Jain re-appointed as Director by rotation.
  • Pranay Godha re-appointed as Director by rotation.
  • Prashant Godha re-appointed as Executive Director for five years from Aug 16, 2026.

Auditor Remuneration

  • Remuneration for ABK & Associates (Cost Auditor) ratified for 2026-27.
Filed 11:02View Source
13 Aug 20261 filing
AGM/EGMAGM

Ipca Laboratories AGM via VC/OAVM discusses dividend, director reappointments, ED remuneration, and cost auditor pay

AGM Details

  • Held 13 August 2026 via VC/OAVM at 3:30 p.m.
  • E-voting 10–12 August 2026; cutoff 7 August 2026.
  • Representatives of auditors and scrutineer attended via VC.
  • Quorum present via VC; all directors attended.
  • Meeting concluded at 4:15 p.m.

Key Resolutions

  • Ordinary: Adoption of Audited Financial Statements for FY2026.
  • Ordinary: Adoption of Audited Consolidated Financial Statements for FY2026.
  • Ordinary: Dividend on equity shares for FY2026.
  • Ordinary: Appointment of Ajit Kumar Jain as Director (retire by rotation).
  • Ordinary: Appointment of Pranay Godha as Director (retire by rotation).
  • Special (Ordinary): Re-appointment of Prashant Godha as Executive Director; remuneration payable.
  • Special (Ordinary): Ratification of remuneration payable to Cost Auditors.

Voting Results

  • Outcome not disclosed in filing; results to be declared after scrutiny.

Dividend

  • Dividend on equity shares proposed for FY ended 31 March 2026; amount per share not disclosed.

Director Changes

  • Ajit Kumar Jain reappointed as Director (retire by rotation).
  • Pranay Godha reappointed as Director (retire by rotation).
  • Prashant Godha reappointed as Executive Director; remuneration payable.

Auditor Appointments

  • Remuneration payable to Cost Auditors ratified.

Material Related Party Transactions

  • No material related party transactions disclosed.

Other Material Approvals

  • No other material approvals disclosed.
Filed 17:33View Source
Showing 10 of 65 filings